#NewMember | "AseBio is a source of new knowledge and a network of companies that integrates and helps us"

AseBio. What does your company's work bring to the table and what is its strength?

José Alberto Ayala. With offices in Spain and the Czech Republic, we provide services to marketing authorization holders of medicines, cosmetics, medical devices, API producers, sponsors of clinical trials and other service providers within the field of Pharmacovigilance, health and life sciences.

Our objective is to help the pharmaceutical industry and new startups to comply with Pharmacovigilance, Clinical Safety, Regulatory and Quality requirements, including GxP audits. We provide global, professional, fast, and flexible solutions to complex and specialized needs.

AseBio. What is AseBio for you?

José Alberto Ayala. AseBio is a forum where we believe we can provide services and solutions to complex problems. It is a source of new knowledge in our field and related fields. It is a network of companies that integrates us and helps us to making the Spanish business and research fields stronger, within a framework of maximum European innovation.

AseBio. When did you first hear about AseBio?

José Alberto Ayala. Several of our projects are with companies that were already part of Asebio.

AseBio. What do you expect from being part of an association like AseBio?

José Alberto Ayala. We hope to contribute with our services in the field of Pharmacovigilance and drug safety, establish new contacts, and learn.

AseBio. What is the biggest challenge facing the biotech sector (or your company)?

José Alberto Ayala. From my point of view, the complex global context that we are experiencing today generates uncertainty. I think it is time to collaborate within a European framework to be number one in innovation.